{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:59:17Z","timestamp":1791097157570,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ijantimicag.2011.12.012","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T00:34:35Z","timestamp":1330994075000},"page":"283-294","source":"Crossref","is-referenced-by-count":190,"title":["Fourteen years in resistance"],"prefix":"10.1016","volume":"39","author":[{"given":"David M.","family":"Livermore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0005","unstructured":"Chantrill C. UK public spending. http:\/\/www.ukpublicspending.co.uk\/uk_health_care_spending_10.html [accessed 20 December 2011]."},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0010","unstructured":"Report by the Comptroller and Auditor General. Improving patient care by reducing the risk of hospital acquired infection: a progress report. National Audit Office; 2004. http:\/\/www.nao.org.uk\/publications\/0304\/improving_patient_care.aspx [accessed 20 December 2011]."},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jhin.2011.05.013","article-title":"Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006\u20132009","volume":"79","author":"Wilson","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhin.2009.08.016","article-title":"Historical and changing epidemiology of healthcare-associated infections","volume":"73","author":"Pearson","year":"2009","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(97)12148-1","article-title":"Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid England and Wales, 1989\u201395","volume":"350","author":"Speller","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/AAC.35.1.147","article-title":"Transferable imipenem resistance in Pseudomonas aeruginosa","volume":"35","author":"Watanabe","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AAC.38.1.71","article-title":"Molecular characterization of an enterobacterial metallo \u03b2-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance","volume":"38","author":"Osano","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0040","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(05)75604-X","article-title":"Carbapenem-hydrolysing IMP-1 \u03b2-lactamase in Klebsiella pneumoniae from Singapore","volume":"353","author":"Koh","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0045","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/319998","article-title":"A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines","volume":"32","author":"Aplasca De Los Reyes","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3201\/eid0201.960108","article-title":"PHLS surveillance of antibiotic resistance England and Wales: emerging resistance in Streptococcus pneumoniae","volume":"2","author":"Speller","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijantimicag.2010.10.023","article-title":"Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation","volume":"37","author":"Cookson","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.idc.2010.11.002","article-title":"Control of methicillin-resistant Staphylococcus aureus","volume":"25","author":"Lee","year":"2011","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-0691.2010.03262.x","article-title":"Trends among pathogens reported as causing bacteraemia in England, 2004\u20132008","volume":"17","author":"Wilson","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jac\/dkp448","article-title":"Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007","volume":"65","author":"Ellington","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0075","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jac\/dkp442","article-title":"Reduction in erythromycin resistance in invasive pneumococci from young children in England and Wales","volume":"65","author":"Henderson","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0085","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1046\/j.1469-0691.2003.00689.x","article-title":"A common clone of erythromycin-resistant Streptococcus pneumoniae in Greece and the UK","volume":"9","author":"Fotopoulou","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/jmm.0.020016-0","article-title":"Continued control of pneumococcal disease in the UK\u2014the impact of vaccination","volume":"60","author":"Gladstone","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0095","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/dkh424","article-title":"Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum \u03b2-lactamases in the UK","volume":"54","author":"Woodford","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0105","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/jac\/dkg353","article-title":"Detection of CTX-M-15 extended-spectrum \u03b2-lactamase in the United Kingdom","volume":"52","author":"Mushtaq","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0110","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dkg096","article-title":"CTX-M extended-spectrum \u03b2-lactamase arrives in the UK","volume":"51","author":"Alobwede","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jac\/dkn380","article-title":"UK epidemic Escherichia coli strains A\u2013E, with CTX-M-15 \u03b2-lactamase, all belong to the international O25:H4-ST131 clone","volume":"62","author":"Lau","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0125","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1128\/AAC.00688-09","article-title":"Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone","volume":"53","author":"Woodford","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0130","doi-asserted-by":"crossref","first-page":"e26578","DOI":"10.1371\/journal.pone.0026578","article-title":"Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms","volume":"6","author":"Totsika","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0135","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dkh397","article-title":"Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum \u03b2-lactamases in York, UK","volume":"54","author":"Munday","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkr041","article-title":"Variation in the genetic environments of blaCTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom","volume":"66","author":"Dhanji","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0145","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/dkp220","article-title":"Nursing homes as a reservoir of extended-spectrum \u03b2-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli","volume":"64","author":"Rooney","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0150","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/jac\/dkq376","article-title":"Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK","volume":"65","author":"Dhanji","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0155","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jac\/dkm517","article-title":"Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum \u03b2-lactamases in the UK","volume":"61","author":"Warren","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/vr.100037","article-title":"Investigation of the presence of ESBL-producing Escherichia coli in the North Wales and West Midlands areas of the UK in 2007 to 2008 using scanning surveillance","volume":"169","author":"Snow","year":"2011","journal-title":"Vet Rec"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jac\/dkq396","article-title":"Prevalence of Escherichia coli carrying extended-spectrum \u03b2-lactamases (CTX-M and TEM-52) from broiler chickens and turkeys in Great Britain between 2006 and 2009","volume":"66","author":"Randall","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1469-0691.2011.03497.x","article-title":"Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains","volume":"17","author":"Leverstein-van Hall","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jac\/49.3.479","article-title":"Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)","volume":"49","author":"Henwood","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhin.2004.05.011","article-title":"A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England","volume":"58","author":"Turton","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0185","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.00699-06","article-title":"Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England","volume":"44","author":"Coelho","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0190","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/AAC.01304-07","article-title":"Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.","volume":"52","author":"Poirel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0200","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.00756-10","article-title":"Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae","volume":"55","author":"Livermore","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0625","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/AAC.01312-09","article-title":"Spread of OXA-48-encoding plasmid in Turkey and beyond","volume":"54","author":"Carr\u00ebr","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jac\/dkn396","article-title":"Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom","volume":"62","author":"Woodford","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0215","series-title":"21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)\/27th International Congress of Chemotherapy (ICC)","article-title":"Enterobacteriaceae producing VIM-1 metallo-\u03b2-lactamases in England\u2014a project for a EUPHEM fellow","author":"Zakikhany","year":"2011"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0220","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/jac\/dkr226","article-title":"Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases","volume":"66","author":"Mushtaq","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0225","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance","volume":"35","author":"Woodford","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0230","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(03)13489-7","article-title":"Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002","volume":"361","author":"Fenton","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0235","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/sextrans-2011-050071","article-title":"Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales","volume":"87","author":"Hughes","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0240","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/jac\/dkq289","article-title":"Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?","volume":"65","author":"Chisholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0245","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/eri.11.103","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management","volume":"9","author":"Ison","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0250","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0255","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","article-title":"UK national guideline for the management of gonorrhoea in adults, 2011","volume":"22","author":"Bignell","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0260","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0265","article-title":"High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure","author":"Unemo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.12.012_bib0270","first-page":"ii75","article-title":"Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001\u201306","volume":"62","author":"Brown","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.12.012_bib0275","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jhin.2005.04.011","article-title":"National glycopeptide-resistant enterococcal bacteraemia surveillance Working Group report to the Department of Health\u2014August 2004","volume":"62","author":"Brown","year":"2006","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0280","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19046-en","article-title":"Emergence and spread of vancomycin resistance among enterococci in Europe","volume":"13","author":"Werner","year":"2008","journal-title":"Euro Surveill"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.12.012_bib0285","first-page":"ii55","article-title":"Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06","volume":"62","author":"Livermore","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0290","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0295","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","author":"van Hal","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.12.012_bib0300","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ijantimicag.2010.11.005","article-title":"Is vancomycin redundant for serious staphylococcal infection?","volume":"36","author":"Gould","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0305","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/AAC.00346-09","article-title":"VanA-type vancomycin-resistant Staphylococcus aureus","volume":"53","author":"Perichon","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0310","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0315","series-title":"49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)\/Infectious Diseases Society of America (IDSA) 46th Annual Meeting","first-page":"96","article-title":"The illusion of MIC creep in MRSA","author":"Reynolds","year":"2009"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0320","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10096-002-0807-0","article-title":"Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit","volume":"21","author":"Johnson","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0325","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/650574","article-title":"Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus","volume":"50","author":"Morales","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0330","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0335","unstructured":"Hornsey M, Wareham DW, Turton JF, Martin K, Pike R, Livermore DM, et al. Emergence of tigecycline and linezolid resistance in a vancomycin-resistant isolate of Enterococcus faecium. In: Abstracts of the 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)\/27th International Congress of Chemotherapy (ICC), 7\u201310 May 2011, Milan, Italy [Abstract P934]. http:\/\/www.eccmidabstracts.com\/abstract.asp?id=92165 [accessed 27 January 2012]."},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0340","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijantimicag.2010.01.011","article-title":"Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment","volume":"35","author":"Hornsey","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0345","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijantimicag.2011.04.021","article-title":"Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates","volume":"38","author":"Yang","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0350","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jac\/dkq408","article-title":"Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates","volume":"66","author":"Livermore","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0355","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jac\/dkg408","article-title":"Two widely disseminated strains of Enterococcus faecalis highly resistant to gentamicin and ciprofloxacin from bacteraemias in the UK and Ireland","volume":"52","author":"Woodford","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.12.012_bib0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/48.suppl_1.29","article-title":"The development of the BSAC standardized method of disc diffusion testing","volume":"48","author":"Andrews","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0365","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1093\/jac\/dkr359","article-title":"BSAC standardized disc susceptibility testing method (version 10)","volume":"66","author":"Andrews","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0375","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.clinthera.2010.04.003","article-title":"Pharmacodynamic modeling of intravenous antibiotics against Gram-negative bacteria collected in the United States","volume":"32","author":"Koomanachai","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0380","unstructured":"A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 1991;27(Suppl. D):1\u201350."},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0385","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2133\/dmpk.DMPK-11-RG-027","article-title":"Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic\/pharmacodynamic considerations","volume":"26","author":"Ohata","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0390","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc10441","article-title":"Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of \u03b2-lactams","volume":"15","author":"Goncalves-Pereira","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0395","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00003246-200102000-00030","article-title":"Impaired target site penetration of \u03b2-lactams may account for therapeutic failure in patients with septic shock","volume":"29","author":"Joukhadar","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0400","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/CMR.00082-09","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"23","author":"Freeman","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0405","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1046\/j.1365-2036.1998.00428.x","article-title":"Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin\u2013tazobactam","volume":"12","author":"Settle","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0410","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkh285","article-title":"Long-term surveillance of cefotaxime and piperacillin\u2013tazobactam prescribing and incidence of Clostridium difficile diarrhoea","volume":"54","author":"Wilcox","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0415","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","author":"Bauer","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0420","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/43.2.261","article-title":"The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage","volume":"43","author":"Bradley","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0425","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/501787","article-title":"Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae","volume":"21","author":"Patterson","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.12.012_bib0430","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/504484","article-title":"Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?","volume":"43","author":"Kollef","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0440","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/eri.11.49","article-title":"The rise of antimicrobial resistance: a clear and present danger","volume":"9","author":"Holmes","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0445","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/jac\/dkr262","article-title":"Discovery research: the scientific challenge of finding new antibiotics","volume":"66","author":"Livermore","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0450","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0455","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dkr259","article-title":"Regulatory opportunities to encourage technology solutions to antibacterial drug resistance","volume":"66","author":"Finch","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0460","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/jac\/dkr260","article-title":"Effective antibacterials: at what cost? The economics of antibacterial resistance and its control","volume":"66","author":"White","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0465","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1586\/eri.11.107","article-title":"Will new antimicrobials overcome resistance among Gram-negatives?","volume":"9","author":"Bassetti","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0470","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1039\/c0cs00131g","article-title":"Boron-containing inhibitors of synthetases","volume":"40","author":"Baker","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0475","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/eri.10.173","article-title":"Activity of a novel combination against multidrug-resistant nonfermenters: ceftazidime plus NXL104","volume":"9","author":"Curcio","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0480","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1021\/jm201465w","article-title":"Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad-spectrum antibacterial agent","volume":"55","author":"Xiao","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0485","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.mib.2010.09.004","article-title":"Combating evolution with intelligent design: the neoglycoside ACHN-490","volume":"13","author":"Armstrong","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0490","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.01181-06","article-title":"Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0495","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diagmicrobio.2010.05.012","article-title":"Comparison of tigecycline with imipenem\/cilastatin for the treatment of hospital-acquired pneumonia","volume":"68","author":"Freire","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0500","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1592\/phco.31.6.527","article-title":"High-dose daptomycin for treatment of complicated Gram-positive infections: a large, multicenter, retrospective study","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0505","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/AAC.00315-11","article-title":"Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009","volume":"55","author":"Richter","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0510","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/omi.2010.0127","article-title":"Designing the next generation of vaccines for global public health","volume":"15","author":"Bagnoli","year":"2011","journal-title":"OMICS"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0515","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0520","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4161\/hv.6.12.12917","article-title":"Searching for the holy grail of a staphylococcal vaccine","volume":"6","author":"Thomsen","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0525","unstructured":"UN Data: a world of information. http:\/\/data.un.org\/ [accessed 20 December 2011]."},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0530","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0732-8893(01)00353-4","article-title":"Prevalence of extended spectrum \u03b2-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998\u201399)","volume":"42","author":"Bell","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0535","first-page":"153","article-title":"Prevalence of extended spectrum \u03b2 lactamase producing Gram negative bacteria in a tertiary care hospital","volume":"115","author":"Mathur","year":"2002","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0540","first-page":"287","article-title":"Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data)","volume":"59","author":"Chaudhuri","year":"2011","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0545","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/jac\/dkr240","article-title":"Increasing prevalence and dissemination of NDM-1 metallo-\u03b2-lactamase in India: data from the SMART study (2009)","volume":"66","author":"Lascols","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0550","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1086\/656921","article-title":"New Delhi metallo 1: have carbapenems met their doom?","volume":"51","author":"Deshpande","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0555","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/jac\/dkr299","article-title":"Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media","volume":"66","author":"Perry","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0560","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1089\/fpd.2010.0581","article-title":"Dissemination of cefotaxime-M-producing Escherichia coli isolates in poultry farms, but not swine farms, in China","volume":"7","author":"Li","year":"2010","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0565","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vetmic.2010.04.025","article-title":"Antimicrobial resistance in Escherichia coli isolates from food animals, animal food products and companion animals in China","volume":"146","author":"Lei","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0570","unstructured":"Anon. Municipal Council of Delhi: 18% DJB water not potable. Reported in Times of India 11 March 2011. http:\/\/articles.timesofindia.indiatimes.com\/2011-03-11\/delhi\/28679651_1_djb-water-drinking-water-samples [accessed 27 January 2012]."},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0575","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1473-3099(11)70059-7","article-title":"Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study","volume":"11","author":"Walsh","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0630","doi-asserted-by":"crossref","first-page":"e17038","DOI":"10.1371\/journal.pone.0017038","article-title":"Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements","volume":"6","author":"Kristiansson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0580","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00220-10","article-title":"Foreign travel is a major risk factor for colonisation with Escherichia coli producing extended-spectrum \u03b2-lactamases: a prospective study with swedish volunteers","volume":"54","author":"T\u00e4ngd\u00e9n","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0585","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.healthpol.2011.06.009","article-title":"Medical tourism: a review of the literature and analysis of a role for bi-lateral trade","volume":"103","author":"Smith","year":"2011","journal-title":"Health Policy"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0590","first-page":"33","article-title":"Medical tourism: globalization of the healthcare marketplace","volume":"9","author":"Horowitz","year":"2007","journal-title":"MedGenMed"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0595","article-title":"Carbapenem-hydrolyzing class D \u03b2-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia","author":"Lahlaoui","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0600","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.46.19718-en","article-title":"Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae France, 2010","volume":"15","author":"Decre","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0610","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.50.20042-en","article-title":"A case of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a patient transferred to Slovenia from Libya November 2011","volume":"16","author":"Pirs","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0615","doi-asserted-by":"crossref","unstructured":"Infectious Diseases Society of America. The 10\u00d7 \u201820 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 2010;50:1081\u20133.","DOI":"10.1086\/652237"},{"key":"10.1016\/j.ijantimicag.2011.12.012_bib0620","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nm0711-772","article-title":"Antibiotic bill doesn\u2019t GAIN enough ground","volume":"17","author":"Ambrose","year":"2011","journal-title":"Nat Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T12:17:45Z","timestamp":1641039465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0924857912000441"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.12.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}